As of 2026-11-14, the EV/EBITDA ratio of Microbix Biosystems Inc (MBX.TO) is -16.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MBX.TO's latest enterprise value is 39.81 mil CAD. MBX.TO's TTM EBITDA according to its financial statements is -2.41 mil CAD. Dividing these 2 quantities gives us the above MBX.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2026-11-11 | -16.49 |
| 2026-11-10 | -17.06 |
| 2026-11-09 | -15.93 |
| 2026-11-06 | -15.93 |
| 2026-11-05 | -16.21 |
| 2026-11-04 | -16.21 |
| 2026-11-03 | -16.78 |
| 2026-11-02 | -16.21 |
| 2026-10-30 | -16.78 |
| 2026-10-29 | -16.21 |
| 2026-10-28 | -16.21 |
| 2026-10-27 | -17.06 |
| 2026-10-26 | -17.62 |
| 2026-10-23 | -17.91 |
| 2026-10-21 | -17.91 |
| 2026-10-20 | -17.91 |
| 2026-10-19 | -17.91 |
| 2026-10-16 | -16.78 |
| 2026-10-15 | -17.06 |
| 2026-10-14 | -17.06 |
| 2026-10-13 | -16.78 |
| 2026-10-09 | -17.34 |
| 2026-10-08 | -17.34 |
| 2026-10-07 | -17.62 |
| 2026-10-06 | -16.78 |
| 2026-10-05 | -16.78 |
| 2026-10-02 | -16.78 |
| 2026-09-30 | -17.34 |
| 2026-09-29 | -17.62 |
| 2026-09-28 | -16.78 |
| 2026-09-25 | -16.49 |
| 2026-09-24 | -16.49 |
| 2026-09-23 | -16.78 |
| 2026-09-22 | -17.06 |
| 2026-09-21 | -17.06 |
| 2026-09-18 | -16.78 |
| 2026-09-17 | -17.34 |
| 2026-09-16 | -17.34 |
| 2026-09-15 | -17.34 |
| 2026-09-14 | -17.34 |
| 2026-09-11 | -17.34 |
| 2026-09-10 | -16.21 |
| 2026-09-09 | -16.49 |
| 2026-09-08 | -15.65 |
| 2026-09-04 | -16.49 |
| 2026-09-03 | -16.21 |
| 2026-09-02 | -16.21 |
| 2026-09-01 | -16.78 |
| 2026-08-31 | -16.78 |
| 2026-08-28 | -17.91 |